Physician profile
Rupesh J Parikh
NPI 1245249689
$67,331.08
in general payments reported to CMS, 2019-2025
60 companies · $7,849 in 2025
The $7,849 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,196 · 2020: $4,225 · 2021: $4,634 · 2022: $19K · 2023: $13K · 2024: $11K · 2025: $7,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $9,532 · Honoraria: $2,506 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,725 · Education: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,626.50 |
| Food and Beverage | $9,531.69 |
| Honoraria | $2,506.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,725.00 |
| Education | $1,169.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18,323.56 | 2019-2023 | |
| Beigene USA, INC. | $7,058.61 | 2022-2024 | Brukinsa, Tevimbra |
| Daiichi Sankyo INC. | $5,677.74 | 2022-2025 | Enhertu, Datroway, Injectafer |
| Acceleron Pharma, INC. | $4,000.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $3,591.26 | 2021-2025 | Calquence, Lynparza, Imfinzi |
| Cti Biopharma Corp. | $3,450.00 | 2022-2023 | Vonjo |
| Lilly USA, LLC | $2,725.45 | 2022-2025 | Verzenio, Jaypirca |
| Pharmaessentia USA Corporation | $2,306.25 | 2023 | Besremi |
| Regeneron Healthcare Solutions, INC. | $2,061.11 | 2021-2025 | Libtayo, Lynozyfic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,753.26 | 2023-2025 | Gilotrif |
| Eisai INC. | $1,675.02 | 2021-2025 | |
| Coherus Oncology, INC. | $1,650.00 | 2021 | |
| Mirati Therapeutics, INC. | $1,590.19 | 2023-2024 | Krazati |
| Amgen INC. | $1,412.22 | 2021-2025 | Lumakras, Blincyto, Nplate |
| Karyopharm Therapeutics INC. | $1,267.45 | 2023-2025 | Xpovio |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $927.22 | 2020-2024 | Opdivo, Eliquis |
| Novartis Pharmaceuticals Corporation | $808.00 | 2019-2025 | |
| Seagen INC. | $570.79 | 2023-2025 | Padcev, Tukysa, Adcetris |
| Beigene, LTD. | $525.00 | 2021 | |
| Medtronic USA, INC. | $400.14 | 2019 | |
| Astellas Pharma US INC | $393.44 | 2023-2025 | Xospata, Vyloy, Padcev |
| Merck Sharp & Dohme LLC | $361.54 | 2020-2025 | Keytruda, Welireg, Keytruda Qlex |
| Exelixis INC. | $355.32 | 2021-2025 | Cabometyx |
| Pfizer INC. | $330.62 | 2022-2025 | |
| Celgene Corporation | $305.54 | 2022-2025 | Reblozyl, Pomalyst |
| Genentech USA, INC. | $304.99 | 2023-2025 | Alecensa, Venclexta, Tecentriq |
| Janssen Biotech, INC. | $253.78 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Sobi, INC | $239.15 | 2024-2025 | |
| Gilead Sciences, INC. | $237.27 | 2021-2025 | Trodelvy |
| Progenics Pharmaceuticals, INC. | $221.93 | 2022-2023 | Pylarify |
| Abbvie INC. | $184.41 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $174.94 | 2020-2022 | |
| Incyte Corporation | $174.08 | 2020-2025 | Jakafi |
| Tempus Ai, INC | $168.62 | 2024-2025 | Xt Cdx |
| Sirtex Medical INC | $163.47 | 2023-2025 | Sir-Spheres Microspheres |
| Alexion Pharmaceuticals, INC. | $150.00 | 2019 | |
| Glaxosmithkline, LLC. | $139.43 | 2023-2025 | Zejula, Ojjaara, Blenrep |
| Genzyme Corporation | $138.03 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $117.92 | 2023 | Tazverik |
| Array Biopharma INC | $111.77 | 2025 | Mektovi, Braftovi, Lorbrena |
| Verastem, INC. | $100.64 | 2019 | |
| Aveo Pharmaceuticals, INC. | $99.95 | 2024 | |
| Genmab U.S., INC. | $99.32 | 2023-2025 | Epkinly, Tivdak |
| Emd Serono, INC. | $91.78 | 2023-2025 | Bavencio |
| Takeda Pharmaceuticals U.S.A., INC. | $86.10 | 2023-2024 | Vpriv, Alunbrig |
| Pharmacyclics LLC, An Abbvie Company | $75.21 | 2023 | Imbruvica |
| Sumitomo Pharma America, INC. | $67.68 | 2023-2025 | Orgovyx |
| Puma Biotechnology, INC. | $59.74 | 2024-2025 | |
| Rigel Pharmaceuticals, INC. | $50.02 | 2023-2025 | Rezlidhia, Gavreto, Tavalisse |
| Jazz Pharmaceuticals INC. | $46.41 | 2023-2024 | |
| Geron Corporation | $46.06 | 2025 | Rytelo |
| Forte Bio-Pharma LLC | $43.24 | 2023-2024 | Prolate, Nalocet |
| Blueprint Medicines Corporation | $30.77 | 2024 | Ayvakit |
| Beone Medicines USA, INC. | $29.97 | 2025 | Brukinsa |
| Azurity Pharmaceuticals, INC. | $25.45 | 2025 | Danziten |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Taiho Oncology, INC. | $21.89 | 2025 | |
| Octapharma USA, INC. | $17.05 | 2023 | Octagam Immune Globulin (Human) |
| Stemline Therapeutics INC. | $16.35 | 2023 | Orserdu |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupesh Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.